Immunoassay for methamphetamine with a new antibody.

Area of Science:

• * Analytical Chemistry
• * Biochemistry
• * Immunology

Background:

• * Development of sensitive and specific detection methods for methamphetamine is crucial for clinical and forensic applications.
• * Previous methods for methamphetamine detection often faced challenges with cross-reactivity and sensitivity.
• * Hapten synthesis and antibody production are key steps in developing immunoassays.

Purpose of the Study:

• * To synthesize novel haptens for methamphetamine and develop specific antibodies.
• * To establish and validate various immunoassay formats for methamphetamine detection.
• * To evaluate the sensitivity and specificity of the developed assays for different applications.

Main Methods:

• * Synthesis of p- and o-aminomethamphetamine as haptens, coupled to carrier proteins (e.g., bovine serum albumin - BSA) using glutaraldehyde or MBS cross-linking reagents.
• * Preparation of anti-methamphetamine antiserum via immunization with hapten-carrier conjugates.
• * Development of enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA) using alkaline phosphatase (ALP) label, and latex agglutination inhibition reaction test (LAIRT).

Main Results:

• * The p-aminomethamphetamine-BSA conjugate produced an antiserum with low cross-reactivity to methylephedrine.
• * ELISA demonstrated superior sensitivity (0.025-0.5 ng/well) compared to EIA (0.3-300 ng/tube).
• * LAIRT achieved a sensitivity of 0.1 micrograms/ml urine, suitable for mass screening.

Conclusions:

• * Novel immunoassays for methamphetamine detection were successfully developed using synthesized haptens and specific antibodies.
• * The developed ELISA and LAIRT offer sensitive and specific methods for quantifying methamphetamine in various matrices.
• * These assays provide valuable tools for drug testing, clinical monitoring, and forensic analysis.